Finch Therapeutics Group (FNCH)
(Real Time Quote from BATS)
$2.54 USD
+0.05 (2.01%)
Updated May 3, 2024 12:10 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
FNCH 2.54 +0.05(2.01%)
Will FNCH be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for FNCH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for FNCH
Finch Therapeutics Group, Inc. (FNCH) Reports Q3 Loss, Misses Revenue Estimates
Ironwood Pharmaceuticals (IRWD) Beats Q3 Earnings Estimates
FNCH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Finch Therapeutics Group, Inc. (FNCH) Upgraded to Buy: Here's Why
Other News for FNCH
CSSE, RVYL and RCAT among mid-day movers
Immutep, Capricor Therapeutics, Cyclacel Pharmaceuticals among healthcare movers
ING, PALI and FNCH among pre-market losers
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
ENPH, SEDG and MEDP are among after hour movers